The hyperlink to a bill draft that precedes a summary contains the most recent version (Introduced/GA/Enacted) of the bill. If the session has ended, the hyperlink contains the latest version of the bill at the time of sine die adjournment. Note that the summary pertains to the bill as introduced, which is often different from the most recent version.


SB18 (BR126) - R. Alvarado

     AN ACT relating to medical coverage.
     Amend KRS 304.17A-254 to establish a policy governing the procedures for an insurer changing an existing agreement with a provider; amend KRS 304.17A-545 to require an insurer offering a health benefit plan to establish a policy governing he procedures for a Managed Care Organization changing an existing agreement with a provider.


SB18 - AMENDMENTS

     SCS1 - Delete original provisions; repeal, reenact, and amend KRS 304.17A-578 to require an insurer offering a health benefit plan to establish a policy governing the procedures for a managed care organization that is changing an existing agreement with a provider; make applicable to new or renewed provider groups after July 1, 2016 ; amend KRS 205.522 to make Section 1 of this bill applicable to managed care organizations that provide Medicaid benefits; make effective January 1, 2017.
     SFA1( R. Alvarado ) - Apply the same procedure requirements to limited health service benefit plans under KRS 304.17C.
     HCS1 - Amend original provisions to require an insurer offering a health benefit plan to establish procedures for changing a participating provider agreement; require 90 days' notice for a material change; establish required information to be included in notice; require certain notices to be sent by certified mail; require certain notices to be sent in an orange-colored envelope; establish when material changes may take effect; allow providers to withdraw if they give insurer's notice of withdrawal at least 45 day prior to material change's effective date; amend KRS 205.522 to make Section 1 of this bill applicable to managed care organizations that provide Medicaid benefits; Amend 304.17C-060 to require insurers issuing limited health service benefit plans to comply with Section 1 of this bill; amend to add a delayed effective date of January 1, 2017.
     HFA1/HM( R. Smart ) - Amend KRS 304.17A-258 to specify that mitochondrial disease is an inborn error of metabolism or genetics to be treated by products defined as "therapeutic food, formulas, and supplements" and that health benefit plans that provide prescription drug coverage shall include in that coverage therapeutic food, formulas, supplements, and low-protein modified food products for the treatment of mitochondrial disease; specify that this act shall take effect January 1, 2017.
     HFA2/HM( R. Smart ) - Amend KRS 304.17A-258 to specify that mitochondrial disease is an inborn error of metabolism or genetics to be treated by products defined as "therapeutic food, formulas, and supplements" and that health benefit plans that provide prescription drug coverage shall include in that coverage therapeutic food, formulas, supplements, and low-protein modified food products for the treatment of mitochondrial disease; specify that this act shall take effect January 1, 2017.
     HFA3( D. Mayfield ) - Amend KRS 304.17A-578 to specify the process for notice of objection to material changes by participating providers.
     HFA4( J. Greer ) - Amend KRS 304.17C-060 to require insurers to establish procedures for changing existing agreements with participating providers.
     CCR1 - Repeal, reenact, and amend KRS 304.17A-578 to require an insurer offering a health benefit plan to establish procedures for changing a participating provider agreement; require 90 days' notice for a material change; establish required information to be included in notice; require certain notices to be sent by certified mail; require certain notices to be sent in an orange-colored envelope; establish when material changes may take effect; to specify the process for notice of objection to material changes by participating providers; amend KRS 205.522 to make Section 1 of this bill applicable to managed care organizations that provide Medicaid benefits; Amend 304.17C-060 to require insurers issuing limited health service benefit plans to comply with Section 1 of this bill; amend to add a delayed effective date of January 1, 2017; Amend KRS 304.17A-258 to specify that mitochondrial disease is an inborn error of metabolism or genetics to be treated by products defined as "therapeutic food, formulas, and supplements" and that health benefit plans that provide prescription drug coverage shall include in that coverage therapeutic food, formulas, supplements, and low-protein modified food products for the treatment of mitochondrial disease; specify that this act shall take effect January 1, 2017.

     Jan 06, 2016 - introduced in Senate
     Jan 07, 2016 - to Health & Welfare (S)
     Feb 17, 2016 - reported favorably, 1st reading, to Calendar with Committee Substitute (1); floor amendment (1) filed to Committee Substitute
     Feb 18, 2016 - 2nd reading, to Rules
     Mar 02, 2016 - posted for passage in the Regular Orders of the Day for Thursday, March 3, 2016
     Mar 03, 2016 - 3rd reading, passed 30-8 with Committee Substitute (1 ) and floor amendment (1)
     Mar 04, 2016 - received in House
     Mar 07, 2016 - to Banking & Insurance (H)
     Mar 16, 2016 - posting waived
     Mar 23, 2016 - reported favorably, 1st reading, to Consent Calendar with Committee Substitute (1)
     Mar 24, 2016 - 2nd reading, to Rules; posted for passage in the Regular Orders of the Day for Friday, March 25, 2016; floor amendment (1) filed to Bill and (2) filed to Committee Substitute
     Mar 28, 2016 - floor amendments (3) and (4) filed to Committee Substitute
     Mar 29, 2016 - 3rd reading, passed 96-1 with Committee Substitute (1 ) and floor amendments (2), (3) and (4); received in Senate
     Apr 01, 2016 - posted for passage for concurrence in House Committee Substitute (1) and floor amendments (2) (3) and (4); Senate refused to concur in House Committee Substitute (1) and floor amendments (2) (3) and (4); received in House; to Rules (H); posted for passage for receding from House Committee Substitutes (1) floor amendments (2) (3) and (4); House refused to recede from Committee Substitutes (1) floor amendments (2) (3) and (4); Conference Committee appointed in House and Senate
     Apr 15, 2016 - Conference Committee report filed in House and Senate; Conference Committee report adopted in House; passed 95-0; received in Senate; posted for passage for consideration of Conference Committee Report; Conference Committee report adopted in Senate; passed 34-3; enrolled, signed by each presiding officer; delivered to Governor
     Apr 27, 2016 - filed without Governor's signature with the Secretary of State